Federal Register / Vol. 72, No. 95 / Thursday, May 17, 2007 / Notices 27823 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meetig will be open to the public 

as indicated below, with attendance 

limited to space availalbe. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact person listed below in advance 

of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

initial Review Group, Digestive Diseases and 

Nutrition C Subcommittee. 

Date: June 28–29, 2007. 

Open: June 28, 2007, 2 p.m. to 2:30 p.m. 

Agenda: To review procedures and discuss 

policy. 

Place: Courtyard by Marriott Crystal City, 

2899 Jefferson Davis Highway, Arlington, VA 

22202. 

Closed: June 28, 2007, 2:30 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott Crystal City, 

2899 Jefferson David Highway, Arlington, VA 

22202. 

Closed: June 29, 2007, 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott Crystal City, 

2899 Jefferson David Highway, Arlington, VA 

22202. 

Contact Person: Dan E. Matsumoto, PhD, 

Scientific Review Administrator, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 749, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–8894, matsumotod@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: May 8, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2428 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Integrated Preclinical/ 

Clinical Program for HIV Topical 

Microbicides. 

Date: June 7–8, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton/Washington, DC/Rockville, 

Executive Meeting Center, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Clayton C. Huntley, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, National Institutes of Health/ 

NIAID/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892–7616, 301–451–

2570, chuntley@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 8, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2430 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Advisory 

Neurological Disorders and Stroke 

Council, May 24, 2007, 8 a.m. to May 

24, 2007, 10 a.m., National Institutes of 

Health, Building 31, 31 Center Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

May 1, 2007, FR: 07–2128; 72. 

The Clinical Trials Subcommittee 

meeting scheduled for May 24, 2007, 

open and closed sessions have changed 

to closed from 8–8:45 a.m. and open 

from 8:45–10 a.m. The meeting is 

partially closed to the public. 

Dated: May 8, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2431 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEATLH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Arthritis and Musculoskeletal 

and Skin Diseases Advisory Council. 

The meeting will be open to the 

public in indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


pwalker on PROD1PC71 with NOTICES